TIMP3 and central nervous system cancer: Fibulin-3 inhibition of TIMP-3 relieves TIMP-3 suppression of ADAM17, which subsequently may enhance glioma angiogenesis via downstream activation of endothelial tabulation [93] and pro-invasive NF-κB signalling [139].